Group 1 - The company TE HEALTHCARE (06877.HK) expects to report a net loss attributable to shareholders of approximately HKD 7.1 million for the year ending December 31, 2025, following a net profit of approximately HKD 11.3 million for the year ending December 31, 2024 [1] - The overall profitability of the company is negatively impacted by significant increases in administrative and operational expenses due to the expansion of B2C sales channels and digital marketing activities [1] - The company anticipates other income of approximately HKD 4.6 million for the year ending December 31, 2025, a decrease of about 71% compared to other income of approximately HKD 16.3 million for the year ending December 31, 2024, attributed to declines in foreign exchange gains and interest-related income [1] Group 2 - The board remains confident in the company's recovery and long-term development prospects, emphasizing the importance of strategic partnerships to enhance B2C growth momentum [2] - The company plans to optimize its product mix, explore new product and channel opportunities, strengthen cost control, streamline fulfillment and supply chain operations, and enhance operational controls [2] - As these measures are gradually implemented and non-recurring costs normalize, the board expects the company's financial performance to improve over time [2]
TE HEALTHCARE(06877.HK)：预计年度股东应占综合亏损净额约710万港元